BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8959532)

  • 1. Clinical and microbiological evaluation of pefloxacin in lower respiratory tract infections.
    Tatsis G; Tsoukalas G; Hatzinikolaou V; Boulbasakos G; Jordanoglou J
    J Int Med Res; 1996; 24(6):478-81. PubMed ID: 8959532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lower respiratory tract infections with amoxycillin/clavulanic acid in adults.
    Tatsis G; Veslemes M; Hadjistavrou C; Votsiou A; Jordanoglou J
    J Int Med Res; 1993; 21(2):98-101. PubMed ID: 8243795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Yap JC; Wang YT; Chan CC; Ng A; Poh SC
    Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.
    Ball P; File TM; Twynholm M; Henkel T
    Int J Antimicrob Agents; 2001 Jul; 18(1):19-27. PubMed ID: 11463522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
    Chuchalin AG; Novikov IuK; Avdeev SN; Belevskiĭ AS
    Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute gout in a patient taking pefloxacin--a case report.
    Kundu AK
    J Indian Med Assoc; 1996 Nov; 94(11):427. PubMed ID: 9141871
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of the new quinolones in lower respiratory infections.
    Davies BI; Maesen FP
    Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of respiratory tract infections with pefloxacin].
    Królikowski W; Głuszko P; Soja J; Prokop A; Wandzilak M; Klisiewicz-Pańszczyk T; Jurek I; Gruszka M; Sek S; Musiał J
    Pol Arch Med Wewn; 1991 Apr; 85(4):210-4. PubMed ID: 1881829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pefloxacin in lower respiratory tract infections.
    Grassi C; Catena E; de Iola G; Ginesu F; Gori M; Lucchini M; Mangiarotti P; Micillo E; Onoscuri M; Orlandi O
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():103-10. PubMed ID: 2258337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P; Köhler D
    Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pefloxacin (abactal) efficacy in severe pneumonia].
    Aleksanian LA
    Antibiot Khimioter; 2001; 46(4):19-21. PubMed ID: 11550502
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
    Fayed DF; Dahmash NS; Saddique AA; Shibl AM
    J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of quinolones in respiratory tract infections.
    Maesen FP; Davies BI; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():74-9. PubMed ID: 3325259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
    Tauchnitz C
    Z Gesamte Inn Med; 1970 Aug; 25(16):734-8. PubMed ID: 4941224
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of infection of the lower respiratory tract. Experience with a new quinolinone: pefloxacin].
    Collimedaglia P; Lugatti E; Manini C
    Clin Ter; 1989 Dec; 131(6):391-5. PubMed ID: 2534367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.